Active Implantable Medical Devices Market Revenue to Attain USD 57.77 Bn by 2035
Published: 02 Feb 2026
Author: Precedence Research
Active Implantable Medical Devices Market Revenue and Trends 2026 to 2035
The global active implantable medical devices market revenue was valued at USD 28.03 billion in 2025 and is expected to attain around USD 57.77 billion by 2035, growing at a CAGR of 7.50% during forecast period.This market is experiencing unprecedented growth, driven by the rising geriatric population and growing demand for minimally invasive procedures.What Factors Drive the Growth of the Active
Active Implantable Medical Devices Market?
The rising global prevalence of heart diseases and neurological disorders is expected to spur the demand for active implantable medical devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, neurostimulators, and other devices, which further contribute to the overall growth of the market during the forecast period. The market’s growth is also primarily supported by the rising shift toward less invasive surgeries and rapid innovations in leadless pacemakers, wireless, and closed-loop technologies, which enhance patient treatment outcomes.
Segment Insights
- By product, the implantable cardioverter defibrillators (ICDs) segment contributed the largest market share in 2025, owing to their critical role in preventing sudden cardiac death caused by cardiac rhythm disorders. The growing prevalence of cardiovascular diseases, particularly among the elderly population, increases the demand for implantable cardioverter defibrillators (ICDs) to continuously monitor heart activity.
- By application, the hospitals segment led the market while holding the largest share in 2025. owing to the high patient volumes suffering from cardiovascular disorders and neurological disorders. Hospitals have established infrastructure, skilled healthcare professionals, and the ability to manage implantation procedures for better treatment outcomes. Hospitals have advanced and sterile environments for implanting devices like ICDs, hearing devices, and neurostimulators. Patients highly prefer hospitals owing to their favourable reimbursement policies.
Regional Insights
North America dominated the global active implantable medical devices market by holding the highest market share in 2025. The region has an advanced healthcare infrastructure and skilled surgeons. The growth of the region is characterized by the rising chronic diseases, a surge in the aging population, increasing demand for minimally invasive procedures, and a rise in FDA approvals. For instance, in September 2025, Medtronic plc, a global leader in healthcare technology, announced that it had received U.S. Food and Drug Administration (FDA) approval for the Altaviva device.
The minimally invasive implantable tibial neuromodulation (ITNM) therapy is inserted near the ankle and designed to treat urge urinary incontinence. Bladder control problems affect an estimated 43 million, or 1 in 6, of U.S. adults. Of those, nearly 16 million people have urged urinary incontinence, a common symptom of overactive bladder (OAB) characterized by a sudden, intense urge to urinate, often followed by involuntary leaks before reaching the bathroom. Additionally, rapid technological innovations in AI-enabled systems, wireless, and closed-loop technologies are significantly enhancing device performance and better patient outcomes.
On the other hand, Asia Pacific is projected to grow at a significant CAGR between 2026 and 2035. The region's fastest growth is attributed to the developing healthcare infrastructure, growing geriatric population, rising awareness of early cardiac intervention, and rising technological innovation in implantable medical devices. The rising prevalence of heart failure, cardiac arrhythmias, hearing disorders, and neurological disorders drives the demand for active implantable medical devices in the region.
Active Implantable Medical Devices Market Coverage
| Report Attribute | Key Statistics |
| Market Revenue in 2025 | USD 28.03 Billion |
| Market Revenue by 2035 | USD 57.77 Billion |
| CAGR from 2026 to 2035 | 7.50% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2025 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa |
Recent Development
- In July 2025, Cochlear Limited, the global leader in implantable hearing solutions, announced the U.S Food and Drug Administration (FDA) approval of the Cochlear Nucleus Nexa System, the world's first and only smart cochlear implant system. The Nucleus Nexa System marks a new chapter in cochlear implants. It’s the world’s first smart cochlear implant system. The new Nexa Implant is built to support future enhancements with upgradable firmware and internal memory.(Source: https://www.prnewswire.com)
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7494
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344